BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Business

  Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets

  Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-based financial markets.

  October 25, 2022

   · 

  1 min read
• Lone Star Bio

  Taysha Gene Therapies Announces Proposed Public Offering of Common Stock - October 25, 2022

  Taysha Gene Therapies, Inc. announced that it intends to offer and sell, subject to market conditions, $30 million of shares of its common stock in an underwritten public offering.

  October 25, 2022

   · 

  4 min read
• Business

  Acorda Third Quarter 2022 Update: Webcast/Conference Call Scheduled for November 1, 2022

  Acorda Therapeutics, Inc. will host a webcast/conference call in conjunction with its third quarter 2022 update and financial results on Tuesday, November 1 at 4:30 p.m. ET.

  October 25, 2022

   · 

  5 min read
• Business

  Masimo to Report Third Quarter 2022 Financial Results after Market Close on Tuesday, November 8

  Masimo (NASDAQ: MASI) will release third quarter 2022 financial results for the period ended October 1, 2022, after the market closes on Tuesday, November 8, 2022.

  October 25, 2022

   · 

  4 min read
• AI in Cancer Diagnostics Market Size, Share, Growth, Report 2022-2030

  The global artificial intelligence in cancer diagnostics market size was estimated at USD 367.71 million in 2021 and it is expected to surpass around USD 5.3 billion by 2030, poised to grow at a CAGR of 34.51% from 2022 to 2030.

  October 25, 2022

   · 

  4 min read
• Business

  Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022

  Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) today announced that the Company expects to report financial and business results for the third quarter of 2022 after the market closes on Tuesday, November 8, 2022.

  October 25, 2022

   · 

  1 min read
• DNA Synthesis Market Size, Share, Trends, Growth, Report 2022-2030

  According to Latest Report Study, the global DNA synthesis market was surpassed at USD 260.7 million in 2021 and is expected to hit around USD 513.80 million by 2030, growing at a CAGR of 7.83% from 2022 to 2030.

  October 25, 2022

   · 

  3 min read
• Business

  STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022

  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 second quarter financial results at 10:00 a.m. ET on November 10, 2022.

  October 25, 2022

   · 

  7 min read
• Business

  Mirati Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Updates

  Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will announce financial results for the third quarter of 2022 along with recent corporate updates on November 8, 2022.

  October 25, 2022

   · 

  3 min read
• DNases, Ligases, And RNA Polymerases Market Size, Report 2022 to 2030

  The global DNases, ligases, and RNA polymerases market size was estimated at USD 611.97 million in 2021 and it is expected to surpass around USD 1.4 billion by 2030, poised to grow at a CAGR of 9.63% from 2022 to 2030.

  October 25, 2022

   · 

  8 min read